Dementia pathophysiology

Revision as of 02:51, 3 October 2020 by SAI (talk | contribs) (→‎Overview)
Jump to navigation Jump to search

Dementia Microchapters

Patient Information

Overview

Classification

Causes

Differential Diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: ,Sabeeh Islam, MBBS[2]

Overview

  • Chronic, progressive neurodegenerative disorder characterized by a global, nonreversible impairment in cerebral functioning.
  • Deteriorating course over up to 8-10 years.
  • Brain lesions are marked by neurofibrillary tangles, senile plaques, neuronal loss, and brain atrophy, with defects in acetylcholine synthesis at the cellular level.


Pathophysiology

While the pathogenesis of AD remains unclear, It is thought that dementia is the result of

  • Overproduction and/or decreased clearance of amyloid beta peptides
  • Accumulation of tau proteins
  • Accumulation of neurofibrillary tangles
  • Production of oxygen radicals and nitric oxide, and inflammatory processes
  • Decreased levels of cholinergic neurotransmission.
  • Over-excitation of the glutamate neurotransmitter system via N-methyl-D-aspartate receptors

These changes are usually present in the hippocampus, amygdala, cortex, and nucleus basalis

Genes


Genes involved in the pathogenesis of dementia include

  • Amyloid precursor protein (APP)
  • Presenilin 1 (PSEN1)
  • Presenilin 2 (PSEN2)
  • Apolipoprotein E (APOE)
  • C9ORF72
  • MAPT
  • GRN

Dementia Microchapters

Patient Information

Overview

Classification

Causes

Differential Diagnosis

References

Template:WH Template:WS